Fibromatosis

from Wikipedia, the free encyclopedia
Classification according to ICD-10
M72 Fibromatoses
M72.0 Fibromatosis of the palmar fascia (Dupuytren's contracture)
M72.1 Knuckle pads
M72.2 Fibromatosis of the plantar fascia (Ledderhose contracture)
M72.4 Pseudosarcomatous fibromatosis
M72.6 Necrotizing fasciitis
M72.9 Fibromatosis, unspecified
D48 New formation of unsafe or unknown behavior at other and unspecified locations
D48.3 Retroperitoneum
D48.4 peritoneum
ICD-10 online (WHO version 2019)

The fibromatosis is a benign connective tissue, which often grows aggressively and infiltrated into the environment. There is a high risk of recurrence after surgical removal . The tumor formation usually starts from myofibroblasts. In general, superficial, non-encapsulated forms with fibroids under 5 cm can be subdivided from deep forms in the chest and abdomen. Degeneration is extremely rare.

Classification

The WHO groups fibromatoses with other connective tissue tumors and fibromas as a class of " fibroblastic- myofibroblastic tumors" and subdivides according to histological malignancy into the groups of benign, locally aggressive / intermediate, rarely metastasizing / intermediate and malignant tumors (but only from the fibrosarcoma and fibromyxoid sarcoma).

There are also hereditary forms such as infantile systemic hyalinosis and infantile myofibromatosis or Zimmermann-Laband syndrome .

Superficial fibromatosis

The different forms often appear together. A distinction is made depending on the location:

Deep fibromatosis

  • Retroperitoneal fibrosis , also Ormond's disease , as fibromatosis between the posterior peritoneum ( retroperitoneal ) and the spine, which often leads to urinary retention ( hydronephrosis ) in the kidneys due to the narrowing of the ureters ( ureter ) . A distinction is made between secondary forms, e.g. B. after radiation, of primary fibromatosis for which an autoimmune cause is being discussed.
  • Sclerosing mediastinitis
  • Sclerosing mesenteritis

Aggressive fibromatoses

The so-called aggressive fibromatoses grow infiltratively and are difficult, often delayed, to treat. In the case of surgical removal, similar to a tumor operation, a resection far in the healthy (in sano) should be aimed for. The success must be secured histopathologically. If this is successful, additional radiation therapy offers no advantage. In the case of incomplete removal and incision margins in the diseased tissue, additional radiation therapy seems to be beneficial and can delay the time to relapse. Overall, however, recurrences are very common and the complications associated with surgery are reported in up to a third of all cases. The indication must therefore be made individually and carefully.

See also

Web links

Commons : Fibromatosis  - Collection of pictures, videos and audio files

Individual evidence

  1. Ursus-Nikolaus Riede, Hans-Eckart Schaefer: General and special pathology. 3. Edition. Thieme-Verlag, Stuttgart 1993, ISBN 3-13-683303-9 , p. 1156.
  2. Christopher D. Fletcher, Krishnan K. Unni, Frederik Mertens: Pathology & Genetics. Tumors of Soft Tissue and Bone . IARC Press, Lyon 2002, ISBN 92-832-2413-2 .
  3. Matthias Keller: The extra-abdominal fibromatosis - evaluation of operative and radiotherapeutic measures with special consideration of the relapse case . Dissertation . TU Munich, 2013.
  4. P Prodinger et al .: Surgical resection and radiation therapy of desmoid tumors of the extremities: results of a supra-regional tumor center In: Int Orthop . 37 (2013), pp. 1987-1993.
  5. SH Shin et al .: Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes In: Journal of Surgical Oncology . 108 (2013), pp. 28-33.